Airfinity
@Airfinity
Followers
2K
Following
1K
Media
279
Statuses
829
Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global lifespan.
London, England
Joined October 2016
Interesting webinar hosted by @Airfinity on From Science to Strategy: Making RSV, hMPV, and PIV vaccines work in the real world. The session discusses the challenges of integrating combinations vaccines, the impact of seasonality on rollout strategies and the global severe burden
0
6
10
Influenza positivity rose by 7% in outpatients and 5% in hospitalised patients since the week before, while RSV and hMPV increased marginally. For outpatients, influenza is the leading cause amongst all ages while hMPV is the second leading cause in children under 14.
0
0
1
Is #hMPV causing the outbreak of respiratory infections in #China? The latest data suggests it's largely driven by influenza. Testing of outpatients show 6% had hMPV, compared to 30% with influenza. #humanmetapneumovirus #globalhealth #respiratoryvirus
1
3
5
Watch our webinar: Countermeasure strategies to prevent an avian influenza pandemic here:
@Airfinity predicts the risk of H5N1 & seasonal influenza reassortment will increase five-fold this winter… experts urging US to consider vaccines for poultry/dairy workers
0
0
3
What's new with bird flu and H5N1 pandemic prevention? Join me, @florian_krammer, Hanna Nohynek, and Bob Kadlec at this webinar to find out. October 10, 10 am ET, free registration at the link below! https://t.co/7Rq4t8SZ7J Thanks to @Airfinity & CSL Seqirus for organizing.
5
31
122
The cost of #Wegovy to prevent one stroke in the US is double what’s paid by Britain’s health service, reveals new analysis by Airfinity. Read our feature in @Bloomberg to find out more. https://t.co/gUi4M8Snzp
bloomberg.com
Novo Nordisk A/S’s obesity shot Wegovy also prevents strokes, heart attacks and death. The price of those benefits is far higher in the US, where the cost of the drug has prompted a political outcry.
1
1
4
Join our @ScienceUnga Webinar: Data for Pandemic Preparedness: New approaches for medical countermeasure (MCM) delivery Live next Wednesday 18th September 2024, 3pm ET/ 8pm BST. Register for free through the UNGA Science Summit online portal below. https://t.co/7M2NFxTNoX
0
1
0
Estimates from @Airfinity suggest that the #us RSV vaccine market will drop by 2030 due to @CDCgov #acip recommendations on #vaccination strategies. #vaccinenation #vaccine #rsv #globalhealth #market
https://t.co/yZzvOQM1Tx
vaccinenation.org
In July 2024 Airfinity announced a reduction in its sales projections for vaccines against Respiratory Syncytial Virus (RSV) for older adults in the US.
0
1
3
With new CDC recommendations, RSV market's long-term value falls sharply in US: Airfinity
fiercepharma.com
A month after a CDC panel
0
2
9
As featured in the @FT today, Airfinity has reduced its sales projections for vaccines against Respiratory Syncytial Virus (#RSV) for older adults in the US from $4.7bn per year to $1.7bn by 2030. Reach out to find out more about our estimate or the burden of RSV.
GSK, Pfizer and Moderna face RSV vaccine sales slump
0
1
0
“There is a 27.5% chance of a COVID-like pandemic in the next 10 years." – @rasbech, Founder and CEO of @Airfinity, at the 2024 Copenhagen Democracy Summit. Watch the full session: https://t.co/Xa8R0nlXEY
0
1
5
Has the pandemic fundamentally changed us or the pathogens which surround us? Our study, featured in @Telegraph, shows over 40 countries or territories have reported at least one infectious disease resurgence that’s 10-fold or more over their pre-pandemic baseline.
Has the pandemic made us sicker? The momentous two year event had a profound impact on health ecosystems globally – but its legacy goes beyond a possible immunity debt. Find out more below 👇 https://t.co/0ylf3AwHwV
0
0
2
Is avian influenza becoming less deadly? New analysis shows that case fatality rate (CFR) has dropped to a 33% average over the last 9 years, from 62% pre-2015. A lower CFR may signal that #H5N1 is becoming more suited to human-human infection. Reach out to learn more.
0
0
1
Over 40 countries have reported at least one #infectious #disease resurgence that's 10-fold or more over their pre #pandemic baseline. Read Airfinity and @business' collaborative report on global disease resurgence below. https://t.co/nUdkES8oRO
bloomberg.com
It's not your imagination: At least 13 communicable diseases are surging past pre-pandemic levels
0
0
2
New analysis by Airfinity shows there has been a 300% rise in approved new #cancer treatments in the last two decades, with the US Cancer Moonshot Goal achievable by 2048. Click below to access the full findings on global cancer #disease burden. https://t.co/y97Zb2UsgQ
airfinity.com
Global cancer prevalence increased by 82.5% from 2000 to 2019 across all cancer types, with breast, colorectal, and prostate cancers being the most widespread globally.
0
1
2
Don't miss this by @Airfinity founder @rasbech Excellent read and charts on why need to go further than a Pandemic Treaty if we are to properly protect ourselves from future threats. The good news: democracies did best with Covid... https://t.co/fEKIZtBqeQ
telegraph.co.uk
Covid-19 was not a once in a lifetime risk. Western allies need more than a global treaty to protect themselves from the next crisis
0
2
4
"The West should be on a war footing for the next pandemic," writes Rasmus Bech Hansen, founder of @Airfinity Covid-19 was not a once in a lifetime risk. Western allies need more than a global treaty to protect themselves from the next crisis. https://t.co/PjqEUGzAVG
telegraph.co.uk
Covid-19 was not a once in a lifetime risk. Western allies need more than a global treaty to protect themselves from the next crisis
7
6
7
Today, the @IFPMA release 'From resistance to resilience: What could the future antibiotic pipeline look like?'. Our analysis shows a more robust pipeline could reduce the potential burden on HICs by up to 63%, highlighting the desperate need for new incentives. Read more below.
New report from @IFPMA discusses future of the antibiotic pipeline over the next 10 years, based on modelling done with @Airfinity. Data shows that the introduction of effective pull incentives by 2025 would see a substantial positive impact: ➡ https://t.co/zTTbhnGpTC
0
0
2
This weekend, Airfinity is at #ACC24, @ACCinTouch's annual scientific conference. Get in touch via obesity@airfinity.com if you would like to get a free briefing with our Chief Medical Officer @hsillesen and Senior Director @BhaskarScience
0
2
2
Airfinity’s latest analysis reveals that #Wegovy could prevent up to 3.1 million cases of #CKD in the US by 2030, with a high coverage scenario among patients with class II and class III #obesity. Learn more in our free weekly obesity market newsletter:
linkedin.com
Welcome to this week's update from Airfinity on the latest developments across the obesity treatment landscape. Sign up for the full newsletter here.
1
0
1